Literature DB >> 203711

Mammary tumors, hepatocellular carcinomas, and pancreatic islet changes in C3H-Avy Mice.

B Sass, M L Vernon, R L Peters, G J Kelloff.   

Abstract

Studies of tumor incidence and assorted lesions found in 187 C3H-Avy mice throughout their natural life-spans revealed the following: Hepatocellular carcinomas occurred in 54.3% of males, mammary carcinomas in 95% of females, pancreatic islet cell adenomas in 9.4% of males and in no females, and pancreatic islet cell hyperplasia in 41% of males and 23% of fefemales. Islet cell hyperplasia and adenomas appeared to consist predominantly of alpha and delta cells. Multiple tumors, or hyperplasia, or both, of a single site or of multiple sites occurred as frequently in males as they did in females--49.6% and 51.7% respectively. The most frequent neoplasms were hepatocellular carcinomas and islet cell tumors or hyperplasia in males (45.7%) and multiple mammary tumors in females (30%). Heretofore unreported tumors found in this strain of mouse were 12 islet cell adenomas, 2 spindle cell tumors of the meninges and olfactory lobes, a squamous cell carcinoma of the nasal turbinates, and a schwannoma of the spermatic cord.

Entities:  

Mesh:

Year:  1978        PMID: 203711     DOI: 10.1093/jnci/60.3.611

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  3 in total

1.  Phenotypic characterization of the KK/HlJ inbred mouse strain.

Authors:  A Berndt; B A Sundberg; K A Silva; V E Kennedy; M A Richardson; Q Li; R T Bronson; J Uitto; J P Sundberg
Journal:  Vet Pathol       Date:  2013-09-05       Impact factor: 2.221

2.  Type C retrovirus production by pancreatic beta cells. Association with accelerated pathogenesis in C3H-db/db ("Diabetes") mice.

Authors:  E H Leiter
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

3.  Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.

Authors:  W Götz; C Schucht; J Roth; F Theuring; R Herken
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.